手机屏幕亮度参数再高，还要看真实体验。近日，有媒体在新疆喀什发起了一场手机屏幕强光挑战。在帕米尔高原户外强光直射下，12款2025年主流手机同 台竞技。结果显示，华为Mate 80 Pro Max无论是在模拟看图片玩游戏的全局亮度测试，以及模拟视频高光的峰值亮度测试中，均做到了画面通透、细节尽 显，领先于其他参与机型。#Mate80超透亮灵珑屏#以双层OLED结构，实现了亮度与功耗的双重飞跃，真正做到了在各种极端光照环境下，都能提供清晰舒 适体验的#Mate80神级好屏#。 ...

Core Insights - The Chinese mid-to-large SUV market is experiencing growth, with sales reaching 716,000 units from January to July, a year-on-year increase of 8.6% [1] - The 2026 Ford Edge L has been launched, priced between 229,800 and 309,800 yuan, focusing on practical features rather than superficial upgrades [1][12] Market Trends - There are nearly 80 models of mid-to-large SUVs currently available, indicating market expansion [1] - The disconnect between perceived demand and actual user experience is becoming more pronounced, with manufacturers focusing on gimmicky features rather than core user needs [1] Product Features - The 2026 Ford Edge L emphasizes quality and comfort, introducing a top-tier hybrid model with luxury materials and advanced features [2] - The vehicle includes heated steering wheels and second-row seats as standard from the mid-tier model, breaking industry norms [3] - Active noise cancellation and soundproofing measures create a quiet cabin environment, enhancing the driving experience [4] Safety and Technology - The 2026 Ford Edge L incorporates a three-tier safety system that includes passive protection, active warnings, and intelligent assistance [6] - The vehicle features a 540° transparent cabin and automatic activation for steep inclines, enhancing visibility and safety [6] - The hybrid model addresses battery safety concerns with robust design and extensive testing, offering an 8-year or 200,000 km warranty [7] Performance and Efficiency - The Edge L offers both fuel and hybrid powertrains, with the hybrid version featuring a 2.0T EcoBoost engine and achieving 0-100 km/h in just 7.1 seconds [9] - The hybrid model boasts a low WLTC combined fuel consumption of 6 liters per 100 km and a range of up to 1,188 km [10][11] Space and Comfort - The vehicle's dimensions and seating configurations cater to family needs, with options for flexible seating arrangements and ample storage space [11] - The Edge L's interior design focuses on comfort and usability, addressing common complaints about space in traditional seven-seat SUVs [11] Conclusion - The 2026 Ford Edge L aims to redefine market value standards by prioritizing practical features and user experience over superficial upgrades, positioning itself as a top choice for family-oriented consumers in the mid-to-large SUV segment [12]

经济观察网据人民财讯12月4日消息，一线城市二手房市场活跃度空前。易居研究院数据显示，11月一 线城市二手住宅成交套数达49033套，创下7个月新高，环比大幅增长20%，甚至超过传统旺季9月的成 交水平。今年前11个月，一线城市二手住宅累计成交519021套，同比增长约5%，为近四年来首次突破 51万套大关。 ...

经济观察网据央视网，俄罗斯塔斯社表示，日本政府已批准2025财年补充预算案，使本财年防卫开支占 GDP比例提升到2%。近年来，日本重金采购美制F35战机，对美返销"爱国者"导弹，组建专门的电子战 部队，升级宙斯盾驱逐舰。这一系列军事动作表明，日本的军事建设已经不是简单的修修补补了。它的 目标是"全领域作战能力"，这背后的扩张野心，藏都藏不住。 ...

贵州百灵（002424）（002424.SZ）实控人姜伟涉嫌内幕交易等问题被证监会立案，姜伟当晚通过公司官微发布公开信回应称，"实践中，经调查确无问题的 情况亦非少数。请各位同事保持冷静，不必过度担忧。" 12月3日晚，贵州百灵发布公告称，公司收到实控人姜伟的通知，其于近日收到中国证监会下发的《立案告知书》。按照该告知书，姜伟因涉嫌内幕交易、 信息披露违法、违反限制性规定转让股票，根据相关法律法规，证监会决定对其进行立案。 苗药企业贵州百灵近年来可谓风雨飘摇，从上市公司到实控人姜伟个人"麻烦"不断。 2023年度年报，贵州百灵被天健会计师事务所（特殊普通合伙）出具了否定意见的《内部控制审计报告》，涉及销售费用计提滞后、财务报告内部控制失效 等问题，公司股票于2024年5月6日被实施其他风险警示，证券简称变更为"ST百灵"。2024年11月，贵州百灵收到中国证监会的《立案告知书》，公司因涉 嫌信息披露违法违规被中国证监会立案调查。 立案调查事项尚未完结之际，2025年4月，贵州百灵2024年度财务报表被审计机构出具了带强调事项段的保留意见的审计报告。保留意见所涉事项为年审会 计师无法就某种苗药产品主要原材料可变 ...

Core Viewpoint - The establishment of the "Yangtze (National) Xinchuang Adaptation Base" marks a significant step for Hubei Province in the field of information technology autonomy and control [1] Group 1 - The base is led by the Yangtze Industrial Group's subsidiary, Yangtze Optoelectronics Supply Chain [1] - It is the first national-level adaptation base in Hubei Province that deeply integrates optoelectronics and Xinchuang [1] - The base aims to create a supply chain resource aggregation platform focusing on autonomous secure computing and intelligent aggregation [1] Group 2 - The construction follows a "1+2+3+N" system, which includes one supply chain platform, two main directions, and three functional areas [1] - The three functional areas are pilot verification, testing and certification, and scenario adaptation [1] - The initiative will expand N key industry Xinchuang application demonstration scenarios, creating a comprehensive service system for "Hubei-produced" Xinchuang [1]

Core Insights - The National Bureau of Statistics reported on December 4 that in the monitoring of prices for 50 important production materials across nine categories in the national circulation market, there were notable price changes in November 2025 [1] Price Changes Summary - 15 products experienced price increases, while 30 products saw price decreases, and 5 products remained stable [1] - Specifically, the price of live pigs (external three yuan) decreased by 2.6% compared to the previous period [1] - The price of coking coal (main coking coal) also saw a decline of 2.5% in the same timeframe [1]

Core Insights - The medical device distribution industry is facing significant challenges due to the expansion of centralized procurement, which has intensified price competition and reduced profit margins for distributors [2][3][4][5]. Group 1: Industry Trends - Centralized procurement for medical devices began in 2020 in Anhui and Fujian, but has recently expanded to most provinces in China, leading to a significant shift in the market landscape [2][10]. - The prices of major medical devices have drastically decreased, with examples including digital X-ray (DR) prices dropping from over 1 million to 200,000, and CT prices falling to historical lows of 600,000 [3][9]. - The ongoing anti-corruption campaign in the medical sector has heightened scrutiny on procurement practices, contributing to the rapid expansion of centralized procurement initiatives [3][12]. Group 2: Distributor Challenges - Many medical device distributors are considering transitioning to other business models, such as focusing on devices that are not yet subject to centralized procurement or moving upstream to manufacturing [4][5]. - The profit margins for distributors have significantly decreased, with some reporting earnings dropping from several million to only tens of thousands due to the competitive bidding process [4][5]. - It is projected that only about 10% of current medical device distributors will remain in the industry post-procurement expansion, primarily focusing on after-sales services [5][8]. Group 3: Manufacturer Responses - Major international manufacturers like GE and Philips are experiencing market share losses due to intensified competition from local companies, which are increasingly winning bids in centralized procurement [6][8]. - Local companies such as Wandong Medical and Mindray have shown strong performance in procurement bids, with Wandong achieving a 47% bid success rate for CT devices [8][9]. - Despite the increased competition, some manufacturers like United Imaging have managed to grow their revenue and profits, indicating that innovation may provide a competitive edge in this challenging environment [9]. Group 4: Future Outlook - The trend of centralized procurement is expected to continue expanding across provinces, with most regions likely to implement such measures within the next 3 to 5 years [12]. - The complexity of nationwide centralized procurement is acknowledged, with regional differences in medical device usage making it more feasible to conduct procurement at the provincial level [12].

Core Viewpoint - The implementation of the "delisting new rules" reflects a strict regulatory stance towards listed companies that violate major delisting regulations, with *ST Suwu being a prominent example facing delisting due to multiple financial misconducts [2][3]. Group 1: Company Specifics - *ST Suwu (600200.SH) has received a delisting decision from the Shanghai Stock Exchange, with its stock entering a 15-day delisting preparation period starting December 9, 2023, and the expected last trading day being December 29, 2023 [2]. - The company has been found guilty of multiple violations, including failing to disclose the actual controller, false reporting in annual reports from 2018 to 2023, and significant omissions regarding related party non-operating fund usage, with a reported balance of 1.693 billion yuan, accounting for 96.09% of the disclosed net assets as of the end of 2023 [2]. - *ST Dongtong (300379.SZ) is also facing delisting due to four consecutive years of financial fraud and fraudulent issuance during a 2022 private placement, with the Shenzhen Stock Exchange planning to terminate its stock listing [3]. Group 2: Regulatory and Legal Context - The regulatory framework is evolving towards a "three-punishment linkage" system, which includes administrative, civil, and criminal penalties for companies involved in major violations [4]. - Legal experts indicate that *ST Suwu and its major shareholders may face civil claims and criminal penalties due to their financial misconduct, emphasizing the need for comprehensive accountability for companies that trigger major delisting risks [5]. - The China Securities Regulatory Commission (CSRC) has highlighted the importance of investor protection in cases of major violations leading to delisting, encouraging companies to take proactive measures to compensate affected investors [5].

Core Insights - The participation of bank wealth management subsidiaries in IPO subscriptions is gaining momentum, with notable involvement in the recent listing of domestic GPU company Moer Thread [1][2]. Group 1: Participation in IPOs - Two bank wealth management subsidiaries, Ningyin Wealth Management and Xingyin Wealth Management, successfully participated in the offline allocation for Moer Thread's IPO, with Ningyin receiving approximately 34,400 shares valued at about 3.93 million yuan and Xingyin receiving around 17,900 shares valued at about 2.04 million yuan [1]. - A total of 267 investors participated in the offline subscription for Moer Thread, setting a record for the highest number of participants in a new stock listing on the Sci-Tech Innovation Board this year [2]. Group 2: Factors for Successful Participation - The successful allocation for bank wealth management subsidiaries was attributed to three main factors: compliance with stock base value requirements, precise pricing by the research team, and efficient collaboration among compliance, risk control, and trading departments [2][7]. - The current number of bank wealth management subsidiaries actively engaging in IPO strategies is limited, with only three to four having successfully participated in offline allocations [3]. Group 3: Market Expectations and Challenges - Following the China Securities Regulatory Commission's decision to allow bank wealth management products to be prioritized in IPO allocations, there were high expectations for rapid adoption of A-share IPO strategies among these subsidiaries [4][5]. - Challenges faced by many bank wealth management subsidiaries include meeting stock base value requirements, insufficient research capabilities, and the lack of efficient operational mechanisms [5][6]. Group 4: Operational Mechanisms - Effective operational mechanisms are crucial for timely submission of subscription materials and pricing information within three trading days after the issuance of the prospectus [8]. - Only a few bank wealth management subsidiaries have established the necessary trading systems and operational processes, while most are still working to streamline inter-departmental workflows [8]. Group 5: Future Outlook - Many bank wealth management subsidiaries are accelerating the implementation of A-share IPO strategies, recognizing the potential for differentiation in product returns [9]. - There is an expectation that if these subsidiaries can maintain a high "inclusion rate" in offline allocations, their product yields could exceed the industry average by 1-2 percentage points [8][9].